 
S0717/75262002000100013.htm
DERMATOMIOSITIS JUVENIL Y EMBARAZO
INTRODUCCION 
 
La dermatomiositis juvenil es un desorden inflamatorio crónico multisistémico    del tejido conectivo, caracterizado por infiltración linfocítica    perivascular e infiltración macrofágica de la piel y los músculos,    de etiología desconocida. Es la miopatía inflamatoria pediátrica    más común (1, 2), y sus manifestaciones    cutáneas incluyen las pápulas de Gottron, rash heliotropo, eritema    difuso y localizado, foto sensibilidad, cambios cuniculares que incluyen telagectasia    periungueal, y alopecia areata (3). Las calcificaciones distróficas    de etiología desconocida (calcinosis), resultan probablemente del daño    previo a la actividad de la enfermedad, se desarrolla en el 40% de los pacientes    con dermatomiositis juvenil y son el mayor contribuyente a la morbilidad (4,    5). Tiene una incidencia de 2-3/100.000/año (6,    7). Antes de 1960, los resultados eran pobres, con más    de un tercio de los pacientes fallecidos por su enfermedad, un tercio con síntomas    permanentes, limitaciones severas, y un tercio recuperándose completamente.    Reportes publicados a través de los 70 y 80 han mostrado una marcada    disminución de su mortalidad (7, 8).
 Con la disminución en la mortalidad, la atención está    cifrada en la morbilidad a largo plazo y en las alteraciones funcionales (7).    Con un tratamiento agresivo los niños con dermatomiositis juvenil generalmente    tienen un futuro provisorio, sin incapacidad o con incapacidad mínima.    Sin embargo, muchos niños tienen una enfermedad crónica, rash    persistente y decaimiento, y se mantienen bajo medicación al menos por    tres años desde el diagnóstico (9). La mortalidad    actualmente se estima cercana al 2% y está frecuentemente relacionada    con vasculitis descontrolada, infección pulmonar, o septicemia en áreas    de calcificación patológica (10). El manejo    de estas pacientes usualmente incluye corticosteroides sistémicos con    o sin agentes inmunosupresivos. La enfermedad cutánea es más difícil    de manejar, pero responde a agentes antimalarios, metrotexato, e inmunoglobulinas    intravenosas (8). Los reportes de dermatomiositis que complican    el embarazo son raros (11). Presentamos el caso del primer    embarazo en pacientes con dermatomiositis juvenil. 
 
CASO CLINICO 
 
D.G.R. 17 años, soltera. En abril de 1993 es derivada desde Calama a    Antofagasta, por un cuadro de dolor en el hemicuerpo izquierdo, asociado a dificultad    en la marcha y caídas frecuentes. Con dolor en ambos brazos, con gran    impotencia funcional que le impide levantarse e incluso afirmar la cabeza. Refiere    leve debilidad palpebral, sin oftalmoplejia ni compromiso facial, reflejos osteotendíneos    normales, sensibilidad conservada. Se observa atrofia de ambas eminencias tenares,    y nódulos en la base de las articulaciones metacarpo falángicas.    No existe cambios en la coloración de la piel, ni dolor a la palpación    de las masas musculares.
 Se realiza punción lumbar que obtiene líquido rico en proteínas.    Con el diagnóstico de Guillan Barré en regresión y probable    miopatía se deriva a Santiago.
 Se establece en Santiago diagnóstico de dermatomiositis juvenil por    los hallazgos en el examen físico, asociado con biopsia de piel que informa    infiltración linfocítica perivascular. Se le realizan 7 operaciones    especialmente en el brazo izquierdo para extirparle nódulos calcinosos    que limitaban su movilidad, y le producían dolor. Se instaura tratamiento    corticoidal el cual mantiene hasta ser ingresada al policlínico de alto    riesgo obstétrico.
 Ingresa a policlínico con los diagnósticos de primigesta, embarazo    de 16 semanas, dermatomiositis en tratamiento. Durante su embarazo evoluciona    satisfactoriamente, es hospitalizada durante 5 días a las 31 semanas    por presentar un cuadro de infección urinaria baja; presenta durante    el embarazo un incremento de peso de 12 kg. En sus controles se le realizan    tres ecografías, a las 11, 24 y 34 semanas.
 Ingresa a las 39 semanas en trabajo de parto; pelvis limite, y por prueba    de trabajo de parto fracasada se decide cesárea.
 Da a luz RN 2400 g, masculino, 48,5 cm, 41 semanas de edad pediátrica,    pequeño para la edad gestacional, Apgar 9-9.
 Recién nacido es dado de alta junto a su madre al cuarto día    sin complicaciones. 
 
DISCUSION 
 
La asociación de la dermatomiositis con el embarazo es inusual, y el    resultado fetal puede ser afectado adversamente (2, 3,    4, 5, 5, 11,    12, 13, 14, 15).    De esta manera tenemos el reporte de un caso de rabdomyolisis y mioglobinuria,    la cual se presentó a las 14 semanas del embarazo y resultó en    aborto espontáneo del feto (16) así como el    establecimiento de dermatomiositis en una mujer embarazada de 38 semanas de    gestación que da a luz a un infante sano (14).
 El impacto de la dermatomiositis con un embarazo no complicado mientras es    activa es muy alta para el feto sin mayores consecuencias para la madre (12).    La severidad de la enfermedad desaparece rápidamente después del    parto (13, 15). En el caso presentado el    resultado perinatal resultó ser favorable.
 A mediados de los setenta, después de la institución de la terapia    convencional con corticoides orales (dosis de 1-2 mg/kg/día), el curso    de la DM juvenil parecía seguir 1 de 3 posibles patrones: unicíclico,    policíclico o crónicamente continuo (17). Se    estima que el rango de tiempo en que la DM juvenil requiere de tratamiento médico    varía de 1,5 años a la vida total del niño en caso de síntomas    persistentes (18, 19). Nuestra paciente    se mantenía con terapia corticoidal al momento de encontrarse en control    en policlínico de alto riesgo. Aparentemente la observación que    la instalación de una terapia inmunosupresiva está asociado con    una disminución de la frecuencia de calcinosis, sugiere que un control    de la inflamación puede ser un factor crítico en la fisiopatofisiología    de estos síntomas, la cual era la principal complicación de nuestra    paciente (20).
 El resultado de las manifestaciones cutáneas, subcutáneas y    facial de la dermatomiositis y el impacto en el bienestar de los pacientes,    así como los resultados perinatales en caso de la asociación con    embarazo no ha sido sistemáticamente estudiados (21).
 Por lo tanto a modo de resumen podemos establecer que la dermatomiositis juvenil    es una enfermedad de muy rara ocurrencia, que los resultados perinatales del    embarazo asociado a esta condición son variables, y que afortunadamente    en nuestro caso los resultados perinatales fueron aceptables. 
 
BIBLIOGRAFIA 
 1. Pchman, L, Lotta-Dais MR, Hong DK, Kinella TR, Méndez    EP, Kinder JM, Chen EH: Tnt(alpha)-308 a allele in juvenile dermatomyositis:    association with increased production of tumor necrosis factor (alpha), disease    duration, and pathologic calcifications-Arthritis and Rheums. 2000; 43(10):    2368-77.         [ Links ] 2. Symmons DPM, Sills JA, Davis SM: The incidence of juvenile    dermatomyositis: results from a nation-wide study. Br J Rheumatol 1995; 34:    732-617.         [ Links ] 3. Jeffrey P, Callen: Dermatomyositis. Lancet 2000; 355: 53-57.          [ Links ] 4. Pachman LM, Hayford JR, Chung A, Daugherty CD, Pallansch    MA, Fink CW et al: Juvenile dermatomyositis at diagnosis: clinical characteristics    of 79 children. J Rheumatol 1998; 25: 1198-204.         [ Links ] 5. Bertorini TE, Sebes JI, Palmieri GMA, Igarashi M, Horner    LH: Diltiazen in the treatment of calcinosis in juvenile dermatomyositis. Neurology    1998; (Suppl 4), 50(4): A204-A05.         [ Links ] 6. Reed AM, Pachman LM, Ober C: Molecular genetic studies    of major histocompatibility complex genes in children with juvenile dermatomyositis:    increased risk associated with HLA-DQA1*0501. Hum Immunol 1991; 32: 235-40.          [ Links ] 7. Huber A, Lang B, Leblanc CI et al: Medium an long    term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.    Arthritis Pneum 2000; 541-49.         [ Links ] 8. Bitnum S, Daeschner CW, Travis LB, Dodge WF, Hopps HC:    Dermatomyositis. J Pediatr 1964; 64: 101-31.         [ Links ] 9. Huber AM, Lang B, Le Blanc CMA, Birdi N, MacNeil I, Feldman    BM: Multicentre study of outcome in juvenile dermatmyositis. Arth Reumath 1998;    S264.         [ Links ]10. Pachman LM: An update on juvenile dermatomyositis. Curr    Opin Rheumatol 1995; 7: 437-41.         [ Links ]11. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
 2. Symmons DPM, Sills JA, Davis SM: The incidence of juvenile    dermatomyositis: results from a nation-wide study. Br J Rheumatol 1995; 34:    732-617.         [ Links ] 3. Jeffrey P, Callen: Dermatomyositis. Lancet 2000; 355: 53-57.          [ Links ] 4. Pachman LM, Hayford JR, Chung A, Daugherty CD, Pallansch    MA, Fink CW et al: Juvenile dermatomyositis at diagnosis: clinical characteristics    of 79 children. J Rheumatol 1998; 25: 1198-204.         [ Links ] 5. Bertorini TE, Sebes JI, Palmieri GMA, Igarashi M, Horner    LH: Diltiazen in the treatment of calcinosis in juvenile dermatomyositis. Neurology    1998; (Suppl 4), 50(4): A204-A05.         [ Links ] 6. Reed AM, Pachman LM, Ober C: Molecular genetic studies    of major histocompatibility complex genes in children with juvenile dermatomyositis:    increased risk associated with HLA-DQA1*0501. Hum Immunol 1991; 32: 235-40.          [ Links ] 7. Huber A, Lang B, Leblanc CI et al: Medium an long    term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.    Arthritis Pneum 2000; 541-49.         [ Links ] 8. Bitnum S, Daeschner CW, Travis LB, Dodge WF, Hopps HC:    Dermatomyositis. J Pediatr 1964; 64: 101-31.         [ Links ] 9. Huber AM, Lang B, Le Blanc CMA, Birdi N, MacNeil I, Feldman    BM: Multicentre study of outcome in juvenile dermatmyositis. Arth Reumath 1998;    S264.         [ Links ]10. Pachman LM: An update on juvenile dermatomyositis. Curr    Opin Rheumatol 1995; 7: 437-41.         [ Links ]11. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
 3. Jeffrey P, Callen: Dermatomyositis. Lancet 2000; 355: 53-57.          [ Links ] 4. Pachman LM, Hayford JR, Chung A, Daugherty CD, Pallansch    MA, Fink CW et al: Juvenile dermatomyositis at diagnosis: clinical characteristics    of 79 children. J Rheumatol 1998; 25: 1198-204.         [ Links ] 5. Bertorini TE, Sebes JI, Palmieri GMA, Igarashi M, Horner    LH: Diltiazen in the treatment of calcinosis in juvenile dermatomyositis. Neurology    1998; (Suppl 4), 50(4): A204-A05.         [ Links ] 6. Reed AM, Pachman LM, Ober C: Molecular genetic studies    of major histocompatibility complex genes in children with juvenile dermatomyositis:    increased risk associated with HLA-DQA1*0501. Hum Immunol 1991; 32: 235-40.          [ Links ] 7. Huber A, Lang B, Leblanc CI et al: Medium an long    term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.    Arthritis Pneum 2000; 541-49.         [ Links ] 8. Bitnum S, Daeschner CW, Travis LB, Dodge WF, Hopps HC:    Dermatomyositis. J Pediatr 1964; 64: 101-31.         [ Links ] 9. Huber AM, Lang B, Le Blanc CMA, Birdi N, MacNeil I, Feldman    BM: Multicentre study of outcome in juvenile dermatmyositis. Arth Reumath 1998;    S264.         [ Links ]10. Pachman LM: An update on juvenile dermatomyositis. Curr    Opin Rheumatol 1995; 7: 437-41.         [ Links ]11. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
 4. Pachman LM, Hayford JR, Chung A, Daugherty CD, Pallansch    MA, Fink CW et al: Juvenile dermatomyositis at diagnosis: clinical characteristics    of 79 children. J Rheumatol 1998; 25: 1198-204.         [ Links ] 5. Bertorini TE, Sebes JI, Palmieri GMA, Igarashi M, Horner    LH: Diltiazen in the treatment of calcinosis in juvenile dermatomyositis. Neurology    1998; (Suppl 4), 50(4): A204-A05.         [ Links ] 6. Reed AM, Pachman LM, Ober C: Molecular genetic studies    of major histocompatibility complex genes in children with juvenile dermatomyositis:    increased risk associated with HLA-DQA1*0501. Hum Immunol 1991; 32: 235-40.          [ Links ] 7. Huber A, Lang B, Leblanc CI et al: Medium an long    term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.    Arthritis Pneum 2000; 541-49.         [ Links ] 8. Bitnum S, Daeschner CW, Travis LB, Dodge WF, Hopps HC:    Dermatomyositis. J Pediatr 1964; 64: 101-31.         [ Links ] 9. Huber AM, Lang B, Le Blanc CMA, Birdi N, MacNeil I, Feldman    BM: Multicentre study of outcome in juvenile dermatmyositis. Arth Reumath 1998;    S264.         [ Links ]10. Pachman LM: An update on juvenile dermatomyositis. Curr    Opin Rheumatol 1995; 7: 437-41.         [ Links ]11. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
 5. Bertorini TE, Sebes JI, Palmieri GMA, Igarashi M, Horner    LH: Diltiazen in the treatment of calcinosis in juvenile dermatomyositis. Neurology    1998; (Suppl 4), 50(4): A204-A05.         [ Links ] 6. Reed AM, Pachman LM, Ober C: Molecular genetic studies    of major histocompatibility complex genes in children with juvenile dermatomyositis:    increased risk associated with HLA-DQA1*0501. Hum Immunol 1991; 32: 235-40.          [ Links ] 7. Huber A, Lang B, Leblanc CI et al: Medium an long    term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.    Arthritis Pneum 2000; 541-49.         [ Links ] 8. Bitnum S, Daeschner CW, Travis LB, Dodge WF, Hopps HC:    Dermatomyositis. J Pediatr 1964; 64: 101-31.         [ Links ] 9. Huber AM, Lang B, Le Blanc CMA, Birdi N, MacNeil I, Feldman    BM: Multicentre study of outcome in juvenile dermatmyositis. Arth Reumath 1998;    S264.         [ Links ]10. Pachman LM: An update on juvenile dermatomyositis. Curr    Opin Rheumatol 1995; 7: 437-41.         [ Links ]11. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
 6. Reed AM, Pachman LM, Ober C: Molecular genetic studies    of major histocompatibility complex genes in children with juvenile dermatomyositis:    increased risk associated with HLA-DQA1*0501. Hum Immunol 1991; 32: 235-40.          [ Links ] 7. Huber A, Lang B, Leblanc CI et al: Medium an long    term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.    Arthritis Pneum 2000; 541-49.         [ Links ] 8. Bitnum S, Daeschner CW, Travis LB, Dodge WF, Hopps HC:    Dermatomyositis. J Pediatr 1964; 64: 101-31.         [ Links ] 9. Huber AM, Lang B, Le Blanc CMA, Birdi N, MacNeil I, Feldman    BM: Multicentre study of outcome in juvenile dermatmyositis. Arth Reumath 1998;    S264.         [ Links ]10. Pachman LM: An update on juvenile dermatomyositis. Curr    Opin Rheumatol 1995; 7: 437-41.         [ Links ]11. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
 7. Huber A, Lang B, Leblanc CI et al: Medium an long    term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.    Arthritis Pneum 2000; 541-49.         [ Links ] 8. Bitnum S, Daeschner CW, Travis LB, Dodge WF, Hopps HC:    Dermatomyositis. J Pediatr 1964; 64: 101-31.         [ Links ] 9. Huber AM, Lang B, Le Blanc CMA, Birdi N, MacNeil I, Feldman    BM: Multicentre study of outcome in juvenile dermatmyositis. Arth Reumath 1998;    S264.         [ Links ]10. Pachman LM: An update on juvenile dermatomyositis. Curr    Opin Rheumatol 1995; 7: 437-41.         [ Links ]11. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
 8. Bitnum S, Daeschner CW, Travis LB, Dodge WF, Hopps HC:    Dermatomyositis. J Pediatr 1964; 64: 101-31.         [ Links ] 9. Huber AM, Lang B, Le Blanc CMA, Birdi N, MacNeil I, Feldman    BM: Multicentre study of outcome in juvenile dermatmyositis. Arth Reumath 1998;    S264.         [ Links ]10. Pachman LM: An update on juvenile dermatomyositis. Curr    Opin Rheumatol 1995; 7: 437-41.         [ Links ]11. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
 9. Huber AM, Lang B, Le Blanc CMA, Birdi N, MacNeil I, Feldman    BM: Multicentre study of outcome in juvenile dermatmyositis. Arth Reumath 1998;    S264.         [ Links ]10. Pachman LM: An update on juvenile dermatomyositis. Curr    Opin Rheumatol 1995; 7: 437-41.         [ Links ]11. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
10. Pachman LM: An update on juvenile dermatomyositis. Curr    Opin Rheumatol 1995; 7: 437-41.         [ Links ]11. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
11. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
12. Harris A, Webley M, Usherwood M, Burge S: Dermatomyositis    presenting in pregnancy. Br J Dermatol 1995; 133(5): 783-85.         [ Links ]13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
13. Oros J, Gil B, Risco Cortes R, Torres V, Cervera Aguilar    R, Ayala AR: Dermatomyositis and eclampsia. Analysis of a case and review of    the literature. Ginecol Obstet Mex 1994; 62: 103-06.         [ Links ]14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
14. Pinheiro GD, Goldenberg J, Atra E, Pereira RB, Camano    L, Schmidt B: Juvenile dermatomyositis and pregnancy: report and literature    review. J Rheumatol 1992; 19(11): 1798-1801.         [ Links ]15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
15. Ohno T, Imai A, Tamaya T: Successful outcomes of pregnancy    complicated with dermatomyositis. Case reports. Gynecol Obstet Invest 1992;    33(3): 187-89.         [ Links ]16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
16. Ishii N, Ono H, Kawaguchi T, Nakajima H: Dermatomyositis    and pregnancy. Case report and review of the literature. Dermatologica 1991;    183(2): 146-49.         [ Links ]17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
17. Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK,    Vamvakas LN, Emmanouel DS: Acute onset of dermatomyositis presenting in pregnancy    with rhabdomyolysis and fetal loss. Scand J Rheumatol 1999; 28(3): 192-19.         [ Links ]18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
18. Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman    R: Intermittent high-dose intravenous methylprednisolone (IV pulse) therapy    prevents calcinosis and shortens disease course in juvenile dermatomyositis    (abstract). Arthritis Rheum 1994; 37(Suppl 6): R10.         [ Links ]19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
19. Pachman LM, Callen AM, Hayford J, Chung A, Sinacore J,    Ramsey-Goldman R: Juvenile dermatomyositis: decreased clacinosis (Ca++) with    intermittent high-dose intravenous methylprednisolone (IV pulse) therapy (abstract).    Arthritis Rheum 1994; 37(Suppl 9): S429.         [ Links ]20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
20. Kimball A, Summers R, Turner M, Dugan E, Hicks J, Miller    F, Rider L: Magnetic resonance imaging detection of occult skin and subcutaneous    abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy.    Arthritis Rheum 2000; 43(8): 1866-73.         [ Links ]21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
21. Huber A, Lang B, Leblanc CI, Birdi N, Bolaria R, Malleson    P, Macneil I, Momy J, Avery G, Feldman B: Medium and long term functional outcomes    in a multicenter cohort of children with juvenile dermatomyositis. J Arthritis    Rheum 2000; 43(3): 541-49.         [ Links ]  *Trabajo recibido en noviembre de 2001 y aceptado para    publicación por el Comité Editor en febrero de 2002. 
